Risperidone in acute and long-term therapy of schizophrenia-a clinical profile

Author： Pajonk F.-G.  

Publisher： Elsevier

ISSN： 0278-5846

Source： Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol.28, Iss.1, 2004-01, pp. : 15-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Long-Acting Injectable Risperidone for the Treatment of Schizophrenia: Clinical Perspectives

By Möller Hans-Jürgen  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1541-1566

Adis International

Access to resources Recommend Favorite

Acute and long-term treatment of schizophrenia: different strategies for positive and negative symptoms?

By Rein W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 216-216

Elsevier

Access to resources Recommend Favorite

Long-Term Healthcare Resource Utilisation and Costs Before and After Initiation of Risperidone Treatment in Patients with Chronic Schizophrenia

By Keegan D.L.  

Clinical Drug Investigation, Vol. 18, Iss. 3, 1999-09 ,pp. : 233-237

Adis International

Access to resources Recommend Favorite

Spotlight on Long-Acting Risperidone in Schizophrenia

By Tracy Swainston Harrison   Karen L. Goa  

American Journal of Drug Delivery, Vol. 2, Iss. 3, 2004-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Long-term risperidone beneficial in behavioural disorders

By  

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite